Ph 1-2 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced GI Malignancies Focusing on Hepatocellular Carcinoma
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- James Harding, MD
Memorial Sloan-Kettering Cancer Center (MSKCC)
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
35 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Chinese People'S Liberation Army 81 Hospital
Nanjing, Jiangsu, China
- West China Hospital, Sichuan University
Chengdu, Sichuan, China
- Irccs Ca Granda Ospedale Maggiore Policlinico
Milan, Lombardy, Italy
- National Cancer Institute of Napoli Irccs G. Pascale
Naples, Italy
- Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea
- Pusan National University Hospital
Busan, South Korea
- Asan Medical Center
Seoul, South Korea
- Samsung Medical Center
Seoul, South Korea
- Seoul National University Hospital
Seoul, South Korea
- the Catholic University of Korea, Seoul St. Mary'S Hospital
Seoul, South Korea
- Changhua Christian Hospital
Changhua, Taiwan
- Chang Gung Medical Foundation - Kaohsiung
Kaohsiung City, Taiwan
- Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, Taiwan
- Chi Mei Hospital, Liouying
Tainan, Taiwan
- Chi Mei Medical Center
Tainan, Taiwan
- National Cheng Kung University Hospital
Tainan, Taiwan
- Mackay Memorial Hospital
Taipei, Taiwan
- Taipei Medical University Hospital
Taipei, Taiwan
- Taipei Veterans General Hospital
Taipei, Taiwan
- Tri-Service General Hospital
Taipei, Taiwan
- Chang Gung Medical Foundation - Linkou
Taoyuan, Taiwan
- the Clatterbridge Cancer Centre Nhs Foundation Trust
Bebington, Wirral, United Kingdom
- Guy'S & St Thomas' Nhs Foundation Trust
London, United Kingdom
- Royal Free Hospital
London, United Kingdom
- the Christie Nhs Foundation Trust
Manchester, United Kingdom
- California Pacific Medical Center
San Francisco, California, United States
- Emory University
Atlanta, Georgia, United States
- the University of Chicago Medical Center
Chicago, Illinois, United States
- the University of Kansas Cancer Center
Westwood, Kansas, United States
- Masonic Cancer Center
Minneapolis, Minnesota, United States
- Washington University
St Louis, Missouri, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Oregon Health and Science University
Portland, Oregon, United States
- Upmc Hillman Cancer Center
Pittsburgh, Pennsylvania, United States
- University of Washington
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2014
- Primary completion
- 29 Feb 2020
- Completion
- 29 Feb 2020
- Last update posted
- 25 Apr 2022
- Registered enrollment
- 140
- Registry id
- NCT02102022
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.